This paper is the result of efforts initially undertaken while the authors were affiliated with the Brookings Institution Global Health Financing Initiative, with funding from the Bill and Melinda Gates Foundation. The Global Health Financing Initiative was created in November 2006 to analyze current and potential innovative financing proposals and make practical recommendations to augment and improve the effectiveness of global health financing. As part of a broader program of work, which includes analysis of existing and proposed innovative financing mechanisms, the authors embarked on an analysis of the global malaria challenge. The goal of studying a particular disease was to develop new innovative financing mechanisms designed to improve the performance of programs targeting that disease, which also could potentially be applied more broadly to other diseases or to health systems generally.
This paper discusses key aspects of the current malaria challenge, and how donors and national malaria control programs have looked to private entities to help address these challenges. It proposes a results‐based contracting approach that builds on current and previous successes in leveraging private sector organizations that could potentially improve the outcomes of future malaria prevention programs. The paper outlines potential benefits as well as potential barriers and challenges of this approach. Finally, the paper proposes a partnering for malaria pilot design that could be used by one or more countries to test the impact of such an approach.
